Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.14M | $0.00 | -$29.63M | -$35.65M | -$7.97 | N/A | -100.00% | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $18.26M | $0.00 | -$12.55M | -$13.22M | -$0.36 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $2.30M | $0.00 | -$12.97M | -$41.91M | -$66.53 | N/A | N/A | N/A | N/A | |||
| IMA | IMAGENEBIO INC | $32.17M | $0.00 | -$28.07M | -$30.74M | -$7.68 | -100.00% | N/A | N/A | N/A | |||
| ACXP | ACURX PHARMACEUTICALS INC | $10.32M | $0.00 | -$10.00M | -$10.00M | -$10.69 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| MRSN | MERSANA THERAPEUTICS INC | $48.81M | $34.77M | -$65.59M | -$74.04M | -$14.62 | 16.14% | 83.02% | N/A | N/A | 2025-11-11 | ||
| ATYR | ATYR PHARMA INC | $85.98M | $0.00 | -$62.26M | -$63.41M | -$0.80 | -100.00% | -100.00% | N/A | N/A | |||
| FGEN | FIBROGEN INC | $43.80M | -$72.84M | $2.18M | -$2.07M | -$0.38 | N/A | N/A | N/A | N/A | |||
| SGMO | SANGAMO THERAPEUTICS INC | $190.98M | $81.71M | -$55.42M | -$64.59M | -$0.29 | 565.52% | -6.02% | N/A | N/A | 2025-10-30 | ||
| PSTV | PLUS THERAPEUTICS INC | $61.54M | $5.32M | -$14.57M | -$19.03M | -$2.03 | -3.49% | -3.22% | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $62.07M | $0.00 | -$33.79M | -$33.79M | -$2.24 | N/A | N/A | N/A | N/A | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $33.92M | $868.00k | -$34.61M | -$50.95M | -$11.94 | -63.88% | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $17.24M | $1.70M | -$18.54M | -$21.11M | -$0.91 | 61.97% | N/A | N/A | N/A | 2025-11-06 | ||
| GRI | GRI BIO INC | $5.16M | $0.00 | -$10.02M | -$11.92M | $3.81 | N/A | N/A | -99.72% | N/A | |||
| UNCY | UNICYCIVE THERAPEUTICS INC | $90.60M | $0.00 | -$30.97M | -$31.56M | -$3.62 | N/A | N/A | N/A | N/A | |||
| TVRD | TVARDI THERAPEUTICS INC | $46.61M | $6.58M | -$13.45M | -$20.89M | -$16.18 | -34.23% | -22.82% | N/A | N/A | 2025-11-13 | ||
| CING | CINGULATE INC | $20.89M | $0.00 | -$17.32M | -$17.96M | -$4.10 | N/A | N/A | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $20.21M | $1.00M | -$20.10M | -$19.31M | -$2.30 | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| SKYE | SKYE BIOSCIENCE INC | $47.72M | $0.00 | -$41.90M | -$42.37M | -$1.07 | N/A | N/A | N/A | N/A | |||
| INTS | INTENSITY THERAPEUTICS INC | $11.20M | $0.00 | -$12.55M | -$12.58M | -$0.82 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.41M | $0.00 | -$14.99M | -$13.10M | -$0.58 | N/A | N/A | N/A | N/A | 2025-12-01 | ||
| IMUX | IMMUNIC INC | $73.59M | $0.00 | -$96.19M | -$96.40M | -$0.95 | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| MDCX | MEDICUS PHARMA LTD | $48.10M | $0.00 | -$16.73M | -$16.51M | -$1.34 | N/A | N/A | N/A | N/A | 2025-11-21 | ||
| NOTE | FISCALNOTE HOLDINGS INC | $62.71M | $109.68M | -$24.45M | -$45.84M | -$3.84 | -15.39% | N/A | N/A | N/A | 2025-11-18 | ||
| JSPR | JASPER THERAPEUTICS INC | $38.52M | $0.00 | -$88.84M | -$90.92M | -$6.03 | N/A | N/A | N/A | N/A | |||
| PASG | PASSAGE BIO INC | $22.71M | $0.00 | -$55.01M | -$56.86M | -$18.16 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| MBRX | MOLECULIN BIOTECH INC | $14.72M | $0.00 | -$26.43M | -$26.55M | -$3.52 | N/A | N/A | N/A | N/A | |||
| PMN | PROMIS NEUROSCIENCES INC | $22.28M | $0.00 | -$8.43M | -$8.43M | -$0.21 | N/A | N/A | N/A | N/A | 2025-11-12 | ||
| VNRX | VOLITIONRX LTD | $47.34M | $1.32M | -$21.60M | -$23.32M | -$0.25 | 35.10% | 125.09% | N/A | N/A | 2025-11-13 | ||
| MTVA | METAVIA INC | $23.71M | $0.00 | -$18.47M | -$18.49M | -$1.49 | N/A | N/A | N/A | N/A | |||
| BMEA | BIOMEA FUSION INC | $86.88M | $0.00 | -$107.23M | -$112.09M | -$3.02 | N/A | N/A | N/A | N/A | 2025-11-04 | ||
| MYO | MYOMO INC | $41.96M | $40.76M | -$7.41M | -$9.32M | -$0.22 | 93.07% | 59.13% | N/A | N/A | 2025-11-05 | ||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.29M | $14.65M | -$9.25M | -$11.09M | -$6.64 | -19.32% | 6.35% | N/A | N/A | |||
| ACET | ADICET BIO INC | $73.61M | $0.00 | -$107.56M | -$117.32M | -$1.29 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $266.26M | $0.00 | -$223.22M | -$236.91M | -$1.11 | -100.00% | N/A | N/A | N/A | 2025-10-30 | ||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.14M | $0.00 | -$7.09M | -$7.09M | -$3.25 | N/A | N/A | N/A | N/A | |||
| ANVS | ANNOVIS BIO INC | $39.95M | $0.00 | -$30.26M | -$30.26M | -$1.99 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| CTSO | CYTOSORBENTS CORP | $53.22M | $34.54M | -$13.83M | -$15.84M | -$0.28 | 12.77% | 3.94% | N/A | N/A | 2025-11-06 | ||
| TIL | INSTIL BIO INC | $130.96M | $0.00 | -$74.48M | -$84.51M | -$12.92 | N/A | N/A | N/A | N/A | |||
| RNXT | RENOVORX INC | $43.24M | $662.00k | -$11.00M | -$10.66M | -$0.38 | N/A | N/A | N/A | N/A | 2025-11-17 | ||
| ATOS | ATOSSA THERAPEUTICS INC | $120.39M | $0.00 | -$28.70M | -$28.72M | -$0.23 | N/A | N/A | N/A | N/A | 2025-11-17 | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $13.32M | $0.00 | -$24.46M | -$26.82M | -$21.31 | N/A | N/A | N/A | N/A | |||
| HBIO | HARVARD BIOSCIENCE INC | $18.17M | $88.75M | -$46.80M | -$57.41M | -$1.29 | -12.24% | -3.39% | N/A | N/A | 2025-11-06 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.